Neuralgap

Neuralgap is a biotech AI startup pioneering explainable, AI-driven drug discovery through our Bioforager platform.

The problem? The market is being flooded with open-source AI drug-discovery models, but medicinal chemists need to understand how and why the resulting drug candidates were selected. This lack of reasoning in AI-sourced drug design is becoming a serious issue. Both the FDA and the EU are enforcing guidance on using AI to support drug-related decision-making, which closely aligns with what we have been building. Our product enables pre-clinical biotech companies to maintain regulatory alignment, reduce risk at the (upstream) computational layer, and get approvals faster.

Our work is gaining traction - commercially with Oak Crest Institute of Science (U.S., 5% royalty on all products), and academically with Universities of Melbourne, Monash, NUS, and Cambridge.